
11 - 50 employees
🧬 Biotechnology
🏥 Healthcare
💰 $150M Series C - Atsena Therapeutics on 2025-04
Biotechnology • Healthcare
Atsena Therapeutics is a clinical-stage gene therapy company developing first- and best-in-class treatments for inherited retinal diseases. Its lead program, ATSN-201, is in a pivotal Phase 3 trial for X-linked retinoschisis (XLRS); other programs include ATSN-101 for LCA1 (pivotal trial planned), and earlier-stage assets targeting Usher Syndrome 1B and Stargardt disease. Atsena uses proprietary AAV-based delivery platforms — notably the laterally spreading capsid AAV. SPR and a dual vector technology — engineered to address retinal delivery challenges and to enable larger gene payloads. The company focuses on advancing ocular gene therapies through clinical development.
🔥 1 hour ago
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
🧬 Biotechnology
🏥 Healthcare
💰 $150M Series C - Atsena Therapeutics on 2025-04
Biotechnology • Healthcare
Atsena Therapeutics is a clinical-stage gene therapy company developing first- and best-in-class treatments for inherited retinal diseases. Its lead program, ATSN-201, is in a pivotal Phase 3 trial for X-linked retinoschisis (XLRS); other programs include ATSN-101 for LCA1 (pivotal trial planned), and earlier-stage assets targeting Usher Syndrome 1B and Stargardt disease. Atsena uses proprietary AAV-based delivery platforms — notably the laterally spreading capsid AAV. SPR and a dual vector technology — engineered to address retinal delivery challenges and to enable larger gene payloads. The company focuses on advancing ocular gene therapies through clinical development.
• Develop and implement global regulatory strategies for gene therapy programs from preclinical through clinical development and commercialization. • Provide regulatory guidance on nonclinical, clinical, and translational development plans. • Identify regulatory risks and propose mitigation strategies to support program timelines. • Contribute to overall product development strategy and lifecycle planning. • Lead preparation and submission of global regulatory filings including: INTERACT and PreINDs, INDs and IND amendments, CTAs and IMPDs, orphan drug designation applications, Fast Track, RMAT and other expedited program submissions. • Ensure high-quality regulatory documentation aligned with agency expectations. • Prepare regulatory briefing documents and support agency meetings. • Serve as a subject matter expert for interactions with agencies including the FDA and EMA. • Coordinate and author responses to health authority questions and information requests. • Partner closely with internal teams including: Clinical Development, Clinical Operations, Nonclinical, Quality. • Serve as a regulatory representative on cross-functional program teams. • Ensure alignment of development plans with global regulatory requirements. • Monitor evolving regulations and guidance related to gene therapies and biologics. • Interpret guidance documents and communicate regulatory expectations internally. • Contribute to development of internal regulatory processes and best practices.
• PhD, PharmD, MD or MS in life sciences, molecular biology, pharmacology, or related discipline. • Direct experience with AAV, lentiviral, or other gene therapy platforms. • Experience with rare disease development programs. • Experience with global regulatory submissions including US and EU. • Prior participation in regulatory agency meetings. • 7–10 years of experience in regulatory affairs within biotech or pharmaceutical industry (for Associate Director). • 10–15+ years of experience in regulatory affairs with demonstrated leadership of regulatory strategy for development programs (for Director). • Proven experience leading regulatory submissions and interactions with agencies. • Strong understanding of regulatory pathways for biologics and gene therapy products. • Experience with nonclinical regulatory requirements for biologics. • Excellent regulatory writing and communication skills. • Ability to lead cross-functional teams and influence program strategy. • Strong project management and organizational skills.
Apply Now🔥 2 hours ago
Sr. Director, Medical Writing leading the preparation of regulatory documents for SAB’s biologic product pipeline. Requires deep expertise in biologics writing for FDA and EMA submissions.
🔥 2 hours ago
Lead the strategic development and execution of the field medical organization for cell therapy. Shape field medical strategy and build relationships with KOLs and clinical investigators.
🔥 2 hours ago
Senior Account Executive selling AI-powered remote patient monitoring systems to physician practices. Owning the full sales cycle and building relationships with medical professionals.
🔥 2 hours ago
Senior Account Executive selling AI-powered remote patient monitoring solutions for physician practices. Managing sales cycle from prospecting through negotiations and building lasting relationships.
🕒 2 days ago
Senior Director of Medical & Scientific Affairs overseeing Specialty Testing business at Beckman Coulter Diagnostics. Leading product development, clinical research, and external partnerships.
🇺🇸 United States – Remote
💵 $260k - $300k / year
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
🦅 H1B Visa Sponsor